| Literature DB >> 31775378 |
Javad Sharifi-Rad1, Farzad Kobarfard1,2, Athar Ata3, Seyed Abdulmajid Ayatollahi1,4, Nafiseh Khosravi-Dehaghi5,6, Arun Kumar Jugran7, Merve Tomas8, Esra Capanoglu9, Karl R Matthews10, Jelena Popović-Djordjević11, Aleksandar Kostić11, Senem Kamiloglu12, Farukh Sharopov13, Muhammad Iqbal Choudhary14, Natália Martins15,16.
Abstract
Members of the Prosopis genus are native to America, Africa and Asia, and have long been used in traditional medicine. The Prosopis species most commonly used for medicinal purposes are P. africana, P. alba, P. cineraria, P. farcta, P. glandulosa, P. juliflora, P. nigra, P. ruscifolia and P. spicigera, which are highly effective in asthma, birth/postpartum pains, callouses, conjunctivitis, diabetes, diarrhea, expectorant, fever, flu, lactation, liver infection, malaria, otitis, pains, pediculosis, rheumatism, scabies, skin inflammations, spasm, stomach ache, bladder and pancreas stone removal. Flour, syrup, and beverages from Prosopis pods have also been potentially used for foods and food supplement formulation in many regions of the world. In addition, various in vitro and in vivo studies have revealed interesting antiplasmodial, antipyretic, anti-inflammatory, antimicrobial, anticancer, antidiabetic and wound healing effects. The phytochemical composition of Prosopis plants, namely their content of C-glycosyl flavones (such as schaftoside, isoschaftoside, vicenin II, vitexin and isovitexin) has been increasingly correlated with the observed biological effects. Thus, given the literature reports, Prosopis plants have positive impact on the human diet and general health. In this sense, the present review provides an in-depth overview of the literature data regarding Prosopis plants' chemical composition, pharmacological and food applications, covering from pre-clinical data to upcoming clinical studies.Entities:
Keywords: C-glycosyl flavones; Prosopis; antiplasmodial; food preservative; vitexin; wound healing potential
Mesh:
Substances:
Year: 2019 PMID: 31775378 PMCID: PMC6995505 DOI: 10.3390/biom9120777
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Structures of the main flavonoids in Prosopis plants.
Figure 2Structures of some C- glycosyl flavones from Prosopis plants.
Figure 3Chemical structures of some phenolic acids from Prosopis plants.
Identification/quantification of phytochemicals in Prosopis species.
| Identified/Quantified Phytochemicals | References | |
|---|---|---|
| Isovitexin (1.12–0.48 μg/mg) | [ | |
| Vicenin II (1.07–0.34 μg/mg) | ||
| Vitexin (0.91–0.47 μg/mg) | ||
| Schaftoside (0.42–0.00 μg/mg) | ||
| Ferulic acid (4.01–0.28 μg/mg) | ||
| Coumaric acid (3.94–0.33 μg/mg) | ||
| Q-dihexoside rhamnoside | [ | |
| Q-dihexoside | ||
| Q-methylether dihexoside | ||
| Vitexin | ||
| Q-rhamnoside hexoside | ||
| Isovitexin | ||
| Q-hexoside | ||
| K-hexoside | ||
| Isoschaftoside hexoside (2.43 mg/g) | [ | |
| Schaftoside hexoside (3.33 mg/g) | ||
| Vicenin II/Isomer (0.67 mg/g) | ||
| Vicenin II/Isomer (2.34 mg/g) | ||
| Isoschaftoside (23.67 mg/g) | ||
| Schaftoside (14.86 mg/g) | ||
| Vitexin (0.46 mg/g) | ||
| Isovitexin (2.09 mg/g) | ||
| Ferulic acid 4-glucuronide (E) | [ | |
| Apigetrin, chrysin (E) | ||
| Chlorogenic acid (E and NE) | ||
| 3-O-feruloylquinic acid (E) | ||
| p-Coumaroylquinic acid (E) | ||
| Valoneic acid dilactone (E) | ||
| Digallic acid (E) | ||
| Ferulic acid (NE) | ||
| Esculetin derivative (NE) | ||
| 7-O-Methylapigenin (NE) | ||
| Cyanidin rhamnosyl hexoside | [ | |
| Cyanidin-3-hexoside | ||
| Peonidin-3-hexoside | ||
| Malvidin dihexoside | ||
| Cyanidin malonoyl hexoside | ||
| Petunidin-3-hexoside | ||
| Malvidin rhamnosyl hexoside | ||
| Malvidin-3-hexoside | ||
| Vicenin II | ||
| Q-dihexoside rhamnoside | ||
| Isoschaftoside | ||
| Q-dihexoside | ||
| Schaftoside | ||
| Q-hexoside rhamnose | ||
| K-hexoside rhamnoside | ||
| Isovitexin | ||
| Q-hexoside | ||
| K-hexoside | ||
| Apigenin hexoside rhamnoside | ||
| Q methyl ether hexoside rhamnoside | ||
| K-methyl ether hexoside rhamnoside | ||
| Vicenin II (0.34 μg/mg) | [ | |
| Schaftoside (0.24 μg/mg) | ||
| Isoschaftoside (0.27 μg/mg) | ||
| Isovitexin (0.81 μg/mg) | ||
| Protocatechuic acid (0.33 μg/mg) | ||
| Coumaric acid (8.16 μg/mg) | ||
| Ferulic acid (4.47 μg/mg) | ||
|
| Protocatechuic acid (31.65 mg/g) Chlorogenic acid (22.31 mg/g) | [ |
| Caffeic acid (6.02 mg/g) | ||
| Ferulic acid (9.24 mg/g) | ||
| Prosogerin A, B, C and D | ||
| β-sitosterol | ||
| Hentriacontane | ||
| Rutin | ||
| Gallic acid | ||
| Patulitrin | ||
| Luteolin | ||
| Spicigerin | ||
|
| Gallic acid (8–25 mg/100 g) | [ |
| Coumaric acid (335–635 mg/100 g) | ||
| Catechin (162.5 mg/100g) | ||
| Gallocatechin (340–648 mg/100 g) | ||
| Epicatechin gallate (10–71 mg/100 g) | ||
| Rutin (222.4–256.1 mg/100 g) | ||
| Morin (236.5 mg/100 g) | ||
| Naringenin (20 mg/100 g) | ||
| Luteolin (13 mg/100 g) | ||
|
| 4′- | [ |
| (+)-catechins | ||
| (-)-mesquitol | ||
| Apigenin | ||
| Luteolin | ||
| Apigenin-6,8-di-C-glycoside | ||
| Chrysoeriol 7- | ||
| Luteolin 7- | ||
| Kaempferol 3- | ||
| Quercitin 3- | ||
| Isoharmentin 3- | ||
| Isoharmentin 3- | ||
| Quercitin 3- | ||
| Quercitin 3- | ||
|
| Gallic acid (8.203 mg/g) | [ |
| Hydroxybenzoic acid (1.797 mg/g) | ||
| Pyrocatechol (5.538 mg/g) | ||
| Caffeic acid (0.295 mg/g) | ||
| Ferulic acid (0.466 mg/g) | ||
| Quercetin (0.045 mg/g) |
Prosopis plants traditionally used in the treatment of various diseases in diverse regions of the world.
| Scientific Name | Location | Local Name | Parts Used | Administration | Disease(s) Treated/Bioactive Effects | References |
|---|---|---|---|---|---|---|
|
| Sélingué subdistrict, Mali | Guele | Bark trunk | Oral, Bath | Malaria | [ |
| Guinea-Bissau | Tentera, Buiengué, Bussagan, Coquengue karbon, Késeg-késeg, Paucarvão, Pócarvão, Pó-de-carbom, Po-di-carvom, Tchelem, Tchalem-ai, tchela, Tchelangadje, Tchelem, Bal-tencali, Culengô, Culim-ô, Djandjam-ô, Quéssem-quéssem, Djeiha, Ogea | Leaves, bark, roots | Unspecified | Pains, pregnancy (childbirth, breastfeeding, diseases of the newborn), skin inflammations (wounds, burns) | [ | |
| Nsukka Local Government Area, South-eastern Nigeria | Ugba | Leaf | Oral | Malaria | [ | |
| North-West Nigeria | Kirya, Ko-hi | Roots | Oral | Analgesic, anti-inflammatory | [ | |
|
| Wichí people of Salta province, Argentina | Jwaayukw, Algarrobo blanco | Resin | Oral | Conjunctivitis, post-abortion pain | [ |
|
| Bahawalnagar, Punjab, Pakistan | Drucey | Leaves, stem | Oral | Spasm, diabetes, liver infection, diarrhea, removal of bladder and pancreas stone, fever, flu | [ |
| Topical | Rheumatism | |||||
| Thar Desert (Sindh), Pakistan | Gujjo | Fruit | Oral | Tonic for body, leucorrhea | [ | |
| South of Kerman, Iran | Kahour | Fruit | Topical | Asthma, skin rash | [ | |
| Pakistan | Unspecified | Flower | Oral | Rheumatism | [ | |
| Hafizabad district, Punjab, Pakistan | Jhand | Leaf, bark, stem, flower, fruit | Oral, topical, eye drop | Liver tonic, boils and blisters, scorpion bite, pancreatic stone, leucorrhoea, chronic dysentery, cataract | [ | |
| Pakistan | Unspecified | Fruit, pods | Unspecified | Asthma | [ | |
| Pakistan | Jandi, Kanda, Kandee, Jhand | Leaves, Bark, Flowers, Pods and wood | Oral | Menstrual disorders, contraceptive, prevention of abortion | [ | |
|
| Jahrom, Iran | Kourak | Fruit | Oral | Constipation, febrifuge | [ |
| Bustamante, Nuevo León, Mexico | Mezquite | Inflorescences | Oral | Stomach pain | [ | |
|
| Thar Desert (Sindh), Pakistan | Devi | Leaves, Gum | Oral | Painkiller, boils opening, eye inflammation, body tonic, muscular pain | [ |
| Hafizabad district, Punjab, Pakistan | Mosquit pod | Whole plant, Flower, Stem, Leaves, Bark | Oral, topical, and as toothbrush | Galactagogue, kidney stones, toothache, breast cancer, asthma, boils | [ | |
| Pakistan | Unspecified | Xerophytic shrub | Unspecified | Asthma, cough | [ | |
| Mohmand Agency, FATA, Pakistan | Kikrye | Leaves | Oral | Lactation, expectorant | [ | |
| Western Madhya Pradesh, India | Reuja | Stem bark | Oral | Asthma | [ | |
|
| Wichí people of Salta province, Argentina | Wosochukw, Algarrobo negro | Resin | Oral | Ocular trauma, conjunctivitis | [ |
|
| Wichí people of Salta province, Argentina | Atek, Vinal | Leaves | Oral | Conjunctivitis, stomachache, pimples/rash, scabies, callouses, fever, birth/postpartum pains, diarrhoea, pediculosis, otitis | [ |
|
| Pakistan | Unspecified | Bark, leaves, flowers | Unspecified | Asthma | [ |
In vitro studies reporting the effect of different Prosopis across the globe.
| Species | Model | Plant Part | Formulation/Dosage | Result | Ref. |
|---|---|---|---|---|---|
|
| |||||
|
| In vitro method | Edible pods | The sugar-free polyphenolic extracts of and obtained from edible pods and anthocyanins enriched extracts | Polyphenolic extracts of | [ |
|
| In vitro method | Seeds | Seeds were pressurized at 500 MPa during 2, 4, 8 and 10 min. | Antioxidant activity, mineral and starch content and bioaccessibility of samples were significantly affected by the processing and digestion conditions. All treatments enhanced the bioaccessibility of the antioxidant activity (IC50), minerals (dialysis and solubility) and starch (resistant and digestible) as compared to the untreated sample | [ |
|
| In vitro method | Stem bark | Methanolic extract of was analyzed and compared with ascorbic acid as reference 10.52 μg/mL (y = 0.4992x + 101.25, 0.9921) and result is 193.54 μg/mL | MPCL can be used as easily an accessible source of natural antioxidants and as a possible food supplement or in pharmaceutical industry | [ |
|
| In vitro method | Aerial part | Oven dried material was grounded into powder (1.5 kg). Powdered materials were soaked in MeOH for 72 h followed by filtration and evaporation. Resulting crude extract was further used for solvent extraction using n-hexane, methylene chloride, ethyl acetate and n-butanol. | [ | |
|
| In vitro method | DNA binding effect was found mainly in the basic fraction. The alkaloids tryptamine as well as piperidine and phenethylamine derivatives were isolated from the basic extracts. | At 0.50 mg/mL, DNA binding activities ranged from 28% for tryptamine to 0–27% for the phenethylamine and 47–54% for the piperidine derivatives. Tryptamine and 2-β-methyl-3-β-hydroxy-6-β-piperidinedodecanol displayed moderate inhibition (27–32%) of β-glucosidase at 100 μg/mL. The exudate of | [ | |
|
| In vitro method | Leaves | Ethanol extract of was investigated for antioxidant activity using in vitro DPPH assay. | Better antioxidant activity (61.55 ± 1.02 RSA %) was found as compared to the control of propyl gallate levels (88 ± 0.07 RSA %) | [ |
|
| In vitro method | Leaves | Leaves were extracted with aqueous acetone (70%) and the polar extract was purified in Sep-Pak® Cartridges and used for evaluation of their fractions. | Significant variations were stated to antioxidant activity among fractions and crude extracts using scavenging hydroxyl and DPPH radical assays | [ |
|
| In vitro method | Edible pods | The sugar-free polyphenolic extracts of and obtained from edible pods and anthocyanins enriched extracts | Extract demonstrated antioxidant activity. Polyphenolic extracts exhibited activity against a pro-inflammatory enzyme | [ |
|
| |||||
|
| In vitro hot-plate method and tail-immersion methods | Roots | Ethanolic extract doses (200 and 300 mg/kg, orally) were selected to study the analgesic activity. | Extracts prevented analgesic property for hot plate and tail immersion method. | [ |
|
| |||||
|
| In vitro method | Leaves | Acetone extracts and purified fractions were dewaxed with petroleum ether and extracted with aqueous acetone (70%); the polar extract was purified and their fractions analyzed | Significant variations among fractions and crude extracts were found in antioxidant capacity by scavenging hydroxyl and DPPH assays. Purified fractions displayed antihypertensive activity, preventing angiotensin converting enzyme and low-density lipoprotein oxidation | [ |
|
| |||||
|
| Chloroquine (CQ)-sensitive | Leaves, stem, flowers and roots | Extraction with methanol, chloroform, hexane, ethyl acetate and aqueous sequentially. These extracts were tested in vitro against laboratory adopted | Ethyl acetate extract of leaf, stem, flower and root and chloroform extract of root showed IC50 values from 5 to 50 μg/mL with good antimalarial activity. Chloroform extracts of leaf, stem, flower and the aqueous extracts of stem, flower and root showed IC50 values of 50–100 μg/mL. The ethyl acetate extract of flower (IC50 = 27.33 μg/mL) showed excellent antimalarial effects. All extracts were non-toxic to THP-1 cells | [ |
|
| In vitro method | Leaves | Two new indolizidine alkaloid, named Δ1,6-juliprosopine and juliprosine were isolated. The structures of these compounds were elucidated using a combination of NMR and MS. | Compound juliprosine showed potent antiplasmodial activity against | [ |
|
|
| Leaf, bark and flower | The filter sterilized ethanol extracts at 100, 50, 25, 12.5, 6.25 and 3.125 μg/mL doses | Leaf, bark and flower extracts of | [ |
|
| |||||
|
|
| MRC-5 cells | Methanol extracted materials screened in vitro against erythrocytic schizonts of intracellular amastigotes of | Antiplasmodial activity was found to the extracts of | [ |
|
| In vitro method | Leaves | Aqueous, petroleum ether, benzene, chloroform, methanol and ethanol extracts and alkaloid extract studied using poisoned food technique against | Aqueous extract recorded significant antifungal activity at 24%. Among different solvent extracts screened, methanol and ethanol extract displayed significantly higher antifungal effects. Methanol extract fractionation leads to the isolation of alkaloid extract with highly significant antifungal activity against the test fungus (minimum inhibitory activity of 1000 ppm). The antifungal activity of alkaloid extract at 2000 ppm or even lower dose was highly effective than the synthetic fungicides. | [ |
|
| In vitro method | Root and stem | Aqueous and ethanol extract was investigated against various microorganisms ( | Ethanol and aqueous extracts of plant parts revealed inhibitory effects on the growth of microorganisms. For both aqueous and ethanol extracts, the inhibitory effect of the stem extract on | [ |
|
| In vitro method | Leaf | Aqueous extract and ethanolic extract for potential antibacterial activity against MRSA isolates | MIC/IBC of aqueous and ethanolic extracts of | [ |
|
| In vitro method | Leaf | Silver nanoparticles (AgNPs) synthesized using an aqueous extract | Concentration-dependent activity was shown against | [ |
|
| In vitro method | Leaves | Ethanolic extract against 17 microorganisms using disc diffusion method | Ethanolic extract exhibited moderate-to-high inhibitory activity against bacteria and fungi. The maximum inhibitory activity was showed against | [ |
|
| In vitro method | Antifungal protein (38.6 kDa) from | Purified protein exerted antifungal activity against post-harvest fruit fungal pathogens | [ | |
|
| In vitro method | Aerial part | Oven dried material was grounded into powder (1.5 kg), soaked in MeOH for 72 h followed by filtration and evaporation. Resulting crude extract was further used for solvent extraction using n-hexane, methylene chloride, ethyl acetate and n-butanol. | [ | |
|
| In vitro method | Acetone, chloroform, diethyl ether, methanol, ethanol and DMSO extract of | DMSO extract displayed the better antibacterial activity against | [ | |
|
| In vitro method | Pods | Antimicrobial activity of alkaloid-enriched extracts from | Basic chloroformic extract (main constituents were juliprosopine, prosoflorine and juliprosine) exhibited antibacterial activity against | [ |
|
| In vitro method | Pods | Six isolates of | The minimum inhibitory concentration (MIC) of | [ |
|
| In vitro method | Comparative assessment of antibacterial activity of crude extract of | [ | ||
|
| In vitro method | Seed pods | Methanol extract of | [ | |
|
| In vitro method | Seed pods | In vitro antibacterial activity of the | [ | |
| In vitro method | Dry extracts, dissolved in DMSO, were tested for inhibition of microbial growth via microplate assay with an oxidation-reduction dye. | [ | |||
|
| In vitro method | Aerial parts | Organic extract was prepared via maceration in methanol, followed by the fractionation using hexane and ethyl acetate. | The best antibacterial activities were detected to the ethyl acetate fraction. The effective antibacterial constituents of the plant were two substances with molecular weight of 348 and 184 Dalton (MIC values <125 to 62.5 μg/mL) | [ |
|
| In vitro method | Pods | Chloroform and benzene extracts | The antimicrobial property was examined by disc diffusion assay against three gram-positive ( | [ |
|
| In vitro method | The antimicrobial alkaloids, juliflorine, julifloricine and benzene insoluble alkaloidal fraction of | Juliflorine was effective on Staphylococcal skin infection. Juliforine at 0.5, 1, and 2.5% were found to heal 25, 50 and 100% lesions in two weeks and microbiological efficacy was found to be 16.66, 33.33, 58.33 and 91.66% with 0.1, 0.5, 1 and 2.5% of juliflorine. Julifloricine was less effective when compared with juliflorine and the benzene insoluble alkaloidal mixture was comparatively more effective than juliflorine. Healing was slightly faster with the mixture. Both juliflorine and the mixture exhibited effectiveness at 2.5% concentration, however these were also found toxic. Gentamicin was found superior to the alkaloids in artificially produced skin infection | [ | |
|
| Crude extracts were with three different solvents and examined for preliminary antibacterial activity | Varying degrees of growth inhibition were shown by all fractions. The highest antibacterial activity was observed for aqueous fractions as compared to solvent fractions. | [ | ||
|
| Human pathogens | Leaf | Characterization of silver (PcAgNPs) and copper nanoparticles (PcCuNPs)was performed using | The bioengineered silver and copper nanohybrids showed enhanced antimicrobial activity against Gram-positive and Gram-negative MDR human pathogens. | [ |
|
| |||||
|
| Roots and leaves | Roots and leaves of | In larval mortality assay, all microencapsulated extracts of | [ | |
|
| Goat gastrointestinal nematodes | pods | In vitro anthelmintic activity of the alkaloid containing fraction | High ovicidal activity was recorded with IC and IC values at 1.1 and 1.43 mg/mL for alkaloid rich fraction. This fraction also exhibited low larvicidal activity and high toxic effect | [ |
|
|
| Bark | Extract in methanol is prepared and used for screening | Time required for the paralysis and death was recorded. Methanol extract was more potent than petroleum ether and aqueous extracts | [ |
|
| In vitro method | Leaves, stem bark and roots | Petroleum ether, chloroform, methanol and aqueous extracts, obtained by cold extraction | All solvent extracts showed strong in vitro anti-trypanosomal activity at both 2 and 4 mg/mL | [ |
|
| |||||
|
| BCL2 protein using molecular docking approach | Five bioactive compounds, namely 2-pentadecanone; butyl 2-ethylhexyl phthalate; methyl 10-methylheptadecanoate; methyl oleate; and phorbol-12, 13- Dihexanoate were identified using GC-MS analysis | Phorbol-12,13-dihexanoate showed best docking score of −15.644 Kcal/mol, followed by methyl oleate (−13.191 Kcal/mol) | [ | |
|
| |||||
|
| In vitro J774A.1 macrophage-derived cell line | Fruits | Fruit extract at varying concentrations in different solvent system | Chloroform (100 μg/mL) produced inhibition of LPS-induced NO production, which was not observed with ethanol and ethyl acetate at the same concentration. NO production inhibition by chloroform (10–100 μg/mL) was dose-dependent, (IC50 = 39.8 (34.4–46.1) μg/mL, and chloroform significantly inhibited LPS-induced iNOS expression in J774A.1 cells | [ |
|
| |||||
|
| Cell lines namely; HepG-2, HeLa, PC3 and MCF-7. | Aerial part | Oven dried material was grounded into powder (1.5 kg), soaked in MeOH for 72 h followed by filtration and evaporation. Resulting crude extract was further used for solvent extraction using n-hexane, methylene chloride, ethyl acetate and n-butanol. | [ | |
|
| Breast cancer cells (MCF-7) | Leaf | Characterization of silver (PcAgNPs) and copper nanoparticles (PcCuNPs) was performed using | MTT assay results indicated that CuNPs show potential cytotoxic effect followed by AgNPs against MCF-7 cancer cell line. IC50 values were 65.27, 37.02 and 197.3 for PcAgNPs, PcCuNPs and | [ |
|
| |||||
|
| Neurons and glial cells | leaves | Total alkaloid extract (TAE) and one alkaloid fraction (F32) at concentrations between 0.3 and 45 μg/mL were tested for 24 h on neuron/glial cell primary cocultures. | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test revealed that TAE and F32 were cytotoxic to cocultures (IC50 were 31.07 and 7.362 μg/mL, respectively). Exposure to a subtoxic concentration of TAE or F32 (0.3–3 μg/mL) induced vacuolation and disruption of the astrocyte monolayer and neurite network, ultrastructural changes, characterized by formation of double-membrane vacuoles, and mitochondrial damage, associated with changes in β-tubulin III and glial fibrillary acidic protein expression. Microglial proliferation was also observed in cultures exposed to TAE or F32, with increasing levels of OX-42-positive cells | [ |
|
|
| Seed pod | A significant increase in the total hemocyte count was found. | [ | |
|
| Neuron/glial cell co-culture | Leaves | A total extract (TAE) of alkaloids and fraction (F32) composed mainly of juliprosopine | TAE (30 μg/mL) and F32 (7.5 μg/mL) reduced ATP levels and led to changes in mitochondrial membrane potential at 12 h exposure. TAE and F32 induced caspase-9 activation, nuclear condensation and neuronal death at 16 h exposure. After 4 h, they induced autophagy characterized by decreases of P62 protein level, increase LC3II expression and increase GFP-LC3 cells number | [ |
ABTS, 2,2’-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid; DMSO, dymethylsulfoxide; DPPH, 1,1-diphenyl-2-picrylhydrazyl; IBC, inhibitory bactericidal concentration; IC50, inhibitory concentration providing 50% of inhibition; LPS, lypopolyssacharide; MIC, minimum inhibitory contentration; RSA, radical scavenging activity.
In vivo studies reporting the effect of different Prosopis across the globe.
| Species | Model | Plant Part | Formulation/Dosage | Result | Ref. |
|---|---|---|---|---|---|
|
| |||||
|
| STZ-induced diabetic rats | Stem bark | Chloroform fraction of species was orally administrated to STZ-induced diabetic rats at the doses of 50 and 100 mg/kg b.w for 21 days | Significant reduction in blood glucose, glycosylated hemoglobin levels and body weight, liver glycogen content and serum insulin level restoration, in a concentration-dependent manner. Decrease in serum lipid profile markers and elevation in HDL after administration, also evidencing protective effects in diabetes-associated complications | [ |
|
| Hyperlipidemic rats | Fruits | Extract was obtained by pulverizing whole dried fruits and extracting with 70% ethanol. | Decrease in serum cholesterol, triglyceride, VLDL and LDL levels. At 400 and 600 mg/kg, the extract significantly reduced serum cholesterol, triglyceride, VLDL, LDL and atherogenic index and these results are almost equivalent to those of drug simvastatin | [ |
|
| Male Swiss albino mice | Bark | Dried material was powdered followed by Soxhlet extraction with 50% aqueous ethanol and concentrated. Oven dried material was suspended in 20% tween 20 in normal saline for further experimentation. | Reduced blood glucose level, enhanced hepatic glycogen content and maintained body weight and lipid-profile attributes towards near normal range. Reduced antioxidant enzymes activity and concentration of non-enzymatic antioxidants, thereby decreasing the oxidative damage in the tissues of diabetic animals and hence indicating the anti-diabetic and antioxidant efficacy of the extract | [ |
|
| Hyperlipidemic rabbits | Bark | Rabbits were orally supplemented with high fat diet and cholesterol powder (500 mg/Kg body weight per day in 5 mL of coconut oil orally for 15 days) to create a hypolipidemic model. | Decreased serum total cholesterol, LDL, triglyceride, VLDL and also ischemic indices (TC/LDL and LDL/HDL). The Prevented the atherogenic changes in aorta. Toxicity profile parameters remained under normal ranges | [ |
|
| Male Wistar rats (type 1 diabetic model) | Half of each group of animals was placed on treatment (100 mg/kg/day) for 8 weeks and the remaining animals served as age-matched controls. | Enhanced insulin levels, with a significant decrease in blood glucose levels. Increased small β-cells level in pancreas. Reduced fasting glucose levels and improved IPGTT. Increased and insulin-stimulated glucose uptake by cardiomyocytes | [ | |
|
| Alloxan-induced diabetic rats | Aerial part | Different animal groups were administered with a single dose of water, extract (100 mg/Kg), tolbutamide (100 mg/Kg, | No evidence of acute toxicity. Blood glucose levels were significantly ( | [ |
|
| |||||
|
| Male Wistar rats | Pod | Aqueous extract of | Comparative assessment of neuronal density of compression and control groups exhibited marked variations. A meaning full variation was recorded between compression and all treatment groups | [ |
|
| |||||
|
| Rats using excision and incision wound model | Ethyl acetate, chloroform and butanol fractions of species hydroethanolic extract were assessed for their antioxidant activity using in vitro method | Butanol fraction found most active fraction against free radicals among all. Butanol fractions possess significant anti-inflammatory, anti-collagenase and anti-elastase activities. Application of butanol fraction ointment for 16 consecutive days on the dorsal wound area of rats confirmed the faster wound repairing process, higher hydroxyproline content, reduction in epithelialization period and inflammatory markers in blood as compared to control group | [ | |
|
| Male albino wistar rats | Leaves | Wound excised rats administered with ethanolic extract for 13 days period. | Decrease in wound area as compared to control | [ |
|
| |||||
|
| Brewer’s-yeast induced pyrexia in albino rat | Leaves and fruits | At a dose of 200 and 300 mg/kg of body weight was investigated. | Reduced hyperpyrexia to a significant level as compared to standard control. Lowered the rectal temperature of rats than fruits extract at 200 mg/kg while at dose of 300 mg/kg both leaves and fruit extract significantly decrease pyrexia. | [ |
|
| Male rats | Twenty-four male rats were randomly allotted to four groups (6 animals per group) and food was deprived off for 48 h water provided but before 24 h of experiment, water also withheld. Group 1 was treated with water for injection (100 mL/kg). Group 2 treated with Paracetamol (150 mg/kg p.o dissolved in water for injection). Group 3 and 4 were treated with ethanol extract of | Decreased the rectal temperature at 3 h and at dose 500 mg/kg. Reduced the rectal temperature at 2, 3 and 4 h in comparison with vehicle control. | [ | |
|
| |||||
|
| In vivo method | Stem bark | The extract at 3–10 mg/mL doses | The extract caused relaxation of the spontaneous as well as K+ (80 mM)-stimulated contractions at tissue bath concentrations of 3–10 mg/mL in isolated rabbit jejunum preparations. Extract displayed nonspecific relaxant effect on carbachol (1 μM)- and K+ (80 mM)-induced contractions in isolated rabbit tracheal preparations. | [ |
|
| |||||
|
| Mice | Leaf | Antidepressant effect was evaluated using Forced swim test (FST). The immobility periods of control and treated mice were recorded. | Leaf extract (200 mg/kg) significantly decreased the duration of immobility time in FST. The efficacy of tested extract was comparable to that of imipramine | [ |
|
| |||||
|
| Rabbit | Root | The study evaluated the efficacy of aqueous extract of | Serum lipid parameters were significantly increased in the high cholesterol diet groups in comparison with the normal control group. Treatment with | [ |
|
| Rabbits | Root | High cholesterol diet–induced NAFLD in rabbits as experimental model. Male rabbits randomly divided into 4 groups namely, control (fed by standard pellet) and other groups were received 2% cholesterol amounts daily. Rabbits were fed with high cholesterol diet till the serum cholesterol level reached 1800 mg/dl, then, they were treated daily with distilled water, and 0.6 mg/kg Simvastatin, or 500 mg/kg/day | Serum lipid parameters and enzymes were significantly enhanced in the high cholesterol diet groups in comparison with the normal control group. Histopathological findings revealed that large lipid vacuoles were formed in hepatocytes. Treatment with | [ |
|
| Wistar albino rats | Beans | Thirty-six male Wistar albino rats weighing 220 ± 30 g were distributed into six groups. Two groups were pretreated with extract (50 and 75 mg/kg) for 7 days before administration of acetaminophen (600 mg/kg). Two were given acetaminophen or extract (50 and 75 mg/kg) alone, and the control received normal saline. | Extract at both doses significantly attenuated total cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, and very low-density lipoprotein levels to near normal | [ |
|
| Rat’s thoracic aorta | In vivo method | [ | ||
|
| |||||
|
| Gastrocnemius muscle of rats | The gastrocnemius muscle of rats was subjected to mass-drop injury and muscle samples collected after 1-, 3 h, 1- and 7 days post-injury. Rats were treated with | Chronic | [ | |
|
| |||||
|
| Stem, leaves, and bark | Performance of 2% bark extract loaded emulsion formulation was determined by using non-invasive probe cutometer and elastometer with comparison to base formulation | Bark extract did not induce any toxicity or apoptosis, when incubated with HaCat cells. Moreover, the formulation (size 3 μm) decreased the skin melanin, erythema and sebum contents up to 2.1-,2.7-and 79%, while increased the skin hydration and elasticity up to 2-folds and 22% as compared to the base, respectively. Owing to enhanced therapeutic effects the phytocosmetic formulation proved to be a potential skin whitening, moisturizer, anti-acne, anti-wrinkle, anti-aging therapy and could actively induce skin rejuvenation and resurfacing | [ | |
|
| |||||
|
| Murine model | Leaves and pods | Alkaloid-enriched extracts from (BCE) of | Alkaloid-enriched extracts from leaves and pods showed remarkable antimalarial activity with little parasitemia inhibition at the 2 mg/kg dose. Julifloridine was weakly active, but juliprosopine caused a parasitemia inhibition at the 2 mg/kg dose similar to that recorded for chloroquine at 50 mg/kg | [ |
|
| |||||
|
| In vivo method | Leaves, stem bark and roots | petroleum ether, chloroform, methanol and aqueous extracts, obtained by cold extraction from the | Only the methanolic extract of leaves displayed promising anti-trypanosomal effect at 200 mg/kg dose | [ |
|
| |||||
|
| Formalin-induced pain test in mice | Fruits | Fruit extract at varying concentrations in different solvent system | Chloroform (300 mg/kg), in contrast to ethanol and ethyl acetate extract, caused significant inhibition of the in vivo nociceptive response. Moreover, chloroform (100–1000 mg/kg, p.o.) produced a dose-dependent inhibition of neurogenic and inflammatory phases of the formalin test with inhibition values (at 600 mg/kg) of 42 ± 7 and 62 ± 7%, respectively. Antinociception was significantly attenuated by i.p. treatment of mice with l-arginine (600 mg/kg) | [ |
IPGTT, Intraperitoneal glucose tolerance test; LDL, low density lipoprotein; NAFLD, Non-alcoholic fatty liver disease; STZ, Streptozotocin; VLDL, very low-density lipoprotein.
Adverse effects and toxicological attributes of Prosopis plants.
| Species | Model | Plant Part | Formulation/Dosage | Result | Ref. |
|---|---|---|---|---|---|
|
| |||||
|
| Wistar rats | In an acute toxicity study | No changes in hematological, biochemical, renal and liver function parameters were stated in experimental animals of in this sub-chronic study when compared to control animals | [ | |
|
| Cattle and goats | Leaves | Cattle and goats experimentally intoxicated presents neurotoxic damage in the central nervous system | Histologic lesions were mainly characterized by vacuolation and loss of neurons in trigeminal motor nuclei. Mitochondrial damage in neurons and gliosis was reported in trigeminal nuclei of intoxicated cattle | [ |
|
| Swiss albino mice | Leaves | Different doses of extract were used for screening. | The extracts of investigated plants are relatively safe at the dose of 100 mg/kg b.w. | [ |
|
| Astrocyte primary cultures derived from the cortex of newborn Wistar rats | In vivo method | TAE and seven alkaloidal fractions, at concentrations ranging 0.03–30 μg/ml | TAE and fractions F29/30, F31/33, F32 and F34/35 were cytotoxic to astrocytes, with EC50 values for the most toxic compounds, TAE, F31/33 and F32, being respectively, 2.87 2.82 and 3.01 μg/mL. Astrocytes exposed to 3 μg/mL TAE, F29/30 or F31/33 developed compact cell body with many processes overexpressing GFAP. Treatment with 30 μg/mL TAE and fractions, induced cytotoxicity characterized by a strong cell body contraction, very thin and long processes and condensed chromatin. Also, the proportion of OX-42 positive cells was increased in cultures treated with 30 μg/mL TAE or F29/30, F31/33, F32 and F34/35, with values raging from 7.27 to 28.74%. Moreover, incubation with 3 μg/mL F32, 30 μg/mL TAE, F29/30, F31/33 or F34/35 induced accumulation of nitrite in culture medium indicating induction of NO production | [ |
|
| Mice | 2,3-Dihydro-1 | PPD showed potent in vivo activity against C. neoformans at 0.0625 mg/kg by eliminating ~76% of the organisms compared to ~83% with Amp B (1.5 mg/kg). In addition, PPD was equally efficacious, but less toxic, at either 0.125 or 0.0625 mg/kg compared to Amp B (1.5 mg/kg) when it was administered bid (twice a day) i.p. When tested by an oral route, PPD (10 mg/kg) showed potent activity in this murine model of cryptococcosis with ~82% of organisms eliminated from the brain tissue, whereas Flu (15 mg/kg) reduced ~90% of the infection. | [ | |
|
| |||||
| Mesquite | Female and male rats | Pod | Female and male rats’ group as vehicle, mesquite pod extract, DAI and E2 were administered subcutaneously for 30 days. | These extracts disrupted both female and male sexual behavior in a similar way to DAI, but less than E2. Mesquite pod extract increased the number of days in estrus and decreased lordosis intensity during proestrus. Mesquite pod extract-treated males showed lower testicular and glandular weights, as well as decreased sperm motility, viability and count. In females treated with mesquite pod extract, the number of pups was lower than in control females, and 10 to 20% of pups were dead. These effects were similar to those with DAI-treatment. Despite the lower sperm quality, the fertility of mesquite pod extract- and DAI-treated males seem not to be disrupted, as they could impregnate control females | [ |
| Mesquite | Male rat | Pod | The following treatments were given to groups of intact male rats: vehicle; mesquite pod extract; E; DAI; GEN. | Mesquite pod extracts disrupt male sexual behavior in a similar way to DAI and GEN, but less than E. The main disruptor of sexual behavior was E, however after 40 and 50 days of administration, extracts and phytoestrogens disrupted sexual behavior in a similar way to E. The extracts also increased testicular germ cell apoptosis, decreased sperm quality, testicular weight, and testosterone levels, as phytoestrogens did, although these effects were less than those caused by estradiol. Number of seminiferous tubules increased in extracts-treated groups in a similar way to phytoestrogens groups, and E caused the greatest effect. Testicular atrophy was only observed in estradiol-treated males. Testosterone declined in males of all experimental groups compared with control. Mesquite pod extracts cause effects similar to those of phytoestrogens in male rat reproduction, these effects were lower than those caused by E | [ |
|
| |||||
| Mesquite | PAR patients | Pollen | Patients demonstrating a positive PST response to mesquite only were used for mesquite conventional subcutaneous ASIT | 86/200 patients displayed a positive PST response to mesquite allergen, of them, 38 were positive to mesquite allergen only. Remarkable attenuation in symptom and medication scores were recorded in 24/38 patients 4 months post-ASIT initiation | [ |
ASIT, Allergen-specific immunotherapy; PST, prick skin testing.